N-([1,1'-Biphenyl]-4-ylmethyl)-2,6-dimethylimidazo[1,2-a]pyridine-3-carboxamide

Catalog No. :
ACFVYV088
CAS No. :
2226192-14-7
Molecular Formula :
C23H21N3O
Molecular Weight :
355.44

IUPAC Name:N-([1,1'-biphenyl]-4-ylmethyl)-2,6-dimethylimidazo[1,2-a]pyridine-3-carboxamide

N-([1,1'-Biphenyl]-4-ylmethyl)-2,6-dimethylimidazo[1,2-a]pyridine-3-carboxamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-([1,1'-Biphenyl]-4-ylmethyl)-2,6-dimethylimidazo[1,2-a]pyridine-3-carboxamide
IUPAC NameN-([1,1'-biphenyl]-4-ylmethyl)-2,6-dimethylimidazo[1,2-a]pyridine-3-carboxamide
Molecular FormulaC23H21N3O
Molecular Weight355.44
SMILESO=C(C1=C(C)N=C2C=CC(C)=CN21)NCC3=CC=C(C4=CC=CC=C4)C=C3
InChI KeyXMWVNUQENAHGHC-UHFFFAOYSA-N
SynonymImidazo[1,2-a]pyridine-3-carboxamide, N-([1,1'-biphenyl]-4-ylmethyl)-2,6-dimethyl-
CAS No.2226192-14-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACFVYV088 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACUBWY401 route compound structure diagram
    ACUBWY40181438-52-0 In Stock
  2. Plus
  3. ACRUYS281 route compound structure diagram
    ACRUYS281712-76-5 In Stock
  4. Then
  5. ACFVYV088 route product structure diagram
    ACFVYV0882226192-14-7
Inquiry

2. ACFVYV088 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQROT208 route compound structure diagram
    ACQROT20898-80-6 In Stock
  4. Then
  5. ACFVYV088 route product structure diagram
    ACFVYV0882226192-14-7
Inquiry

Comments (0)